Imagia Completes Acquisition of Cadens Medical Imaging
Ce communiqué n'est disponible que dans la langue dans laquelle il a été rédigé.
Cision, 15 novembre 2017 – Imagia, a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems, today announced the completion of its acquisition of Cadens Medical Imaging (Cadens), a technology leader in medical imaging software. Since 2008, Cadens has developed and marketed FDA and CE cleared innovative medical imaging software products for cancer care. An ISO 13485 company, Cadens has extensive experience in delivering patient benefits through AI-based software products. Cadens created and validated unique foundational technologies and intellectual property intended to enable Imagia to foster new collaborative biomarker discovery processes that will scale across multiple healthcare institutions.